Clinical trials
Completed Hemolysis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
| Apellis Pharmaceuticals, Inc. | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| AO GENERIUM | 2 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Novartis Pharmaceuticals | 2 |
| University of Mississippi, Oxford | 2 |
| Ain Shams University | 1 |
| Amsterdam UMC, location VUmc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemolysis | 65 |
| Anemia | 12 |
| Hemoglobinuria, Paroxysmal | 9 |
| Anemia, Hemolytic | 7 |
| Hematologic Diseases | 7 |
| Anemia, Sickle Cell | 5 |
| Anemia, Hemolytic, Autoimmune | 4 |
| Hemoglobinuria | 4 |
| Hepatitis C | 4 |
| Fibrosis | 3 |
Trials
Showing 26 to 50 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.